NP / PA
Henry-Walker, Sarah
Henry-Walker, Sarah was paid $140K by Medicaid between Nov 2020 and Oct 2024, across 18 billing codes. Its largest line is 87491, Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe — 24% of everything it billed.
33Billing provider infoHENRY-WALKER, SARAH
ERIE, PA 16502
ERIE, PA 16502
33aNPI1346278447assigned 06/28/2006
33bProvider typeObstetrics & Gynecology Nurse Practitioner
28Total paid$140K
24GClaims4,252
24DCodes billed18
24AFirst – last monthNov 2020 – Oct 2024
Compared with peers
Next to other Obstetrics & Gynecology Nurse Practitioner providers in Pennsylvania
Rank by total paid#4 of 12
Median peer was paid$30K
This provider vs. median4.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 32 | $1K | |
| 2021 | 440 | $15K | |
| 2022 | 869 | $29K | |
| 2023 | 2,019 | $69K | |
| 2024incomplete | 892 | $25K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 24% | 926 | 907 | $33K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 23% | 926 | 907 | $33K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 16% | 377 | 336 | $23K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 6.4% | 304 | 303 | $9K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 6.0% | 84 | 81 | $8K |
| 87480 | 5.8% | 330 | 324 | $8K | |
| 87660 | 5.2% | 330 | 324 | $7K | |
| 86780 | 3.8% | 324 | 323 | $5K | |
| 87510 | 3.8% | 306 | 300 | $5K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.4% | 93 | 93 | $2K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.1% | 13 | 13 | $2K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 1.1% | 37 | 37 | $2K |
6 more codes
| 86803 | <1% | 43 | $898.70 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 12 | $788.76 |
| 81025 | <1% | 59 | $698.56 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 21 | $317.73 |
| 81003 | <1% | 20 | $68.20 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 0% | 47 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.